Q3 Report 2022

Watch the on demand webcast covering
the Q3 Report presentation from the 27th October

  • Revenue 66.2 MSEK (45.2)
  • EBITDA 2.5 MSEK (1.2)
  • Cash flow 9.9 MSEK (14.3)
Read more

Interim Report Q3 2022

Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday October 27, 2022 at 08:00 CET.

Calendar

09 February Feb 2023

Press contact

Carin Jakobson
Carin Jakobson
CFO

Employed 2022

Born: 1974

Education: MSc in Economics Linnaeus University

Background: CFO positions at, among others, Stille, Sivers IMA and Rolling Optics

Other assignments:

Shareholdings: 144 092 call options

Contact us
Bactiguard - A Swedish innovation

Bactiguard was founded in 2005, but our technology is almost a hundred years old. It stems from the Swedish Nobel prize laureate in Physics 1912, Gustav Dahlén.

How the Bactiguard technology works

The Bactiguard Infection Protection (BIP) technology is based on a very thin noble metal alloy coating, firmly attached to medical devices.

Our products prevent healthcare associated infections

The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.